← Browse by Condition
Medical Condition
metastatic urothelial cancer
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 2, Phase 3
NCT03547973 Phase 2
Recruiting
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Enrollment
827 pts
Location
United States, Franc...
Sponsor
Gilead Sciences
NCT06225596 Phase 2, Phase 3
Recruiting
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
Enrollment
956 pts
Location
United States, Argen...
Sponsor
BicycleTx Limited